Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
Clinical trial NCT03060720 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03060720
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2017-02-24
- Primary completion
- 2019-04-07
- Enrollment
- 271
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.